- I will be surprised if they did not get funding. If some were willing to invest $70mil when VCR was trading at above 60c, then surely common sense tells you that some will want to invest at 5c.
- $4bil market.
The Chairman of Ventracor, Mr. John Ward, said: “It is particularly disappointing that after nearing completion of recruitment in the Company’s BTT trial the company is unable to attract sufficient capital to fund its operations through to 30 June 2009. There are now almost 400 people who have been implanted with the VentrAssist® (LVAD), and results to date have been very promising. With the filing of over 2,500 pages of the first module of the application for Pre-Market Approval with the US FDA, the Company has moved one step closer to full commercialisation of the VentrAssist LVAD, and is well positioned to benefit from adoption of LVADs as a long term solution to heart failure.”
VCR Price at posting:
4.9¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
